“Olympus’ continued failure to meet FDA requirements demonstrates a troubling disregard for patient safety,” said Jeffrey ...

The FDA issued draft guidance on oncology clinical trials, taking the first steps toward formalizing a position that it's ...

A U.S. appeals court revived a lawsuit on Friday by healthcare and drug industry groups challenging the first-ever U.S. law ...

The U.S. is one of only two countries that legally allows drugmakers to advertise products directly to patients. There are ...

The Federal Trade Commission took action Friday against the three largest pharmacy benefit managers, accusing the companies ...

Proposal submitted for FDA 505(b)(2) regulatory pathway for SPC-15 approvalAdvancing path to IND submission for first-in-human trialsSARASOTA, ...

“These are scams,” said Kenny Biddle, the chief investigator for the Center of Inquiry, an organization devoted to defending ...

The Federal Trade Commission (FTC) on Friday sued the three largest pharmacy benefit managers (PBMs) for engaging in alleged ...

The FDA is considering food labels to help consumers identify products with unhealthy ingredients, but some experts wonder if ...

The agency alleges CVS’s Caremark, Cigna’s Express Scripts and UnitedHealth’s Optum Rx accepted money from drugmakers in ...

Elisabeth Rosenthal Triumphant music plays as cancer patients go camping, do some gardening, and watch fireworks in ads for Opdivo+Yervoy, a combination of immunotherapies to treat […] ...

Merck’s cancer immunotherapy Keytruda is the drug industry’s biggest blockbuster, bringing in $25 billion in sales last year.